155 related articles for article (PubMed ID: 36323430)
21. Vulvar High-Grade Squamous Intraepithelial Lesions Treated with Imiquimod: Can Persistence of Human Papillomavirus Predict Recurrence?
Fernández-Montolí ME; Heydari F; Lavecchia F; Pavón MÂ; Guerra E; Matias-Guiu X; Marti MD; Tous S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230731
[No Abstract] [Full Text] [Related]
22. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia.
Winters U; Daayana S; Lear JT; Tomlinson AE; Elkord E; Stern PL; Kitchener HC
Clin Cancer Res; 2008 Aug; 14(16):5292-9. PubMed ID: 18698049
[TBL] [Abstract][Full Text] [Related]
23. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Richel O; de Vries HJ; van Noesel CJ; Dijkgraaf MG; Prins JM
Lancet Oncol; 2013 Apr; 14(4):346-53. PubMed ID: 23499546
[TBL] [Abstract][Full Text] [Related]
24. Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.
Trager MH; Rizk E; Rose S; Zhu K; Lau B; Fullerton BT; Pradhan J; Moore M; Srivastava AC; Singer G; Gartrell R; Chang R; Geskin LJ; Saenger YM; Goldenberg G
Sci Rep; 2021 Apr; 11(1):8775. PubMed ID: 33888854
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells.
Barnetson RS; Satchell A; Zhuang L; Slade HB; Halliday GM
Clin Exp Dermatol; 2004 Nov; 29(6):639-43. PubMed ID: 15550144
[TBL] [Abstract][Full Text] [Related]
26. Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response.
Hajiran A; Chakiryan N; Aydin AM; Zemp L; Nguyen J; Laborde JM; Chahoud J; Spiess PE; Zaman S; Falasiri S; Fournier M; Teer JK; Dhillon J; McCarthy S; Moran-Segura C; Katende EN; Sexton WJ; Koomen JM; Mulé J; Kim Y; Manley B
Clin Exp Immunol; 2021 Apr; 204(1):96-106. PubMed ID: 33346915
[TBL] [Abstract][Full Text] [Related]
27. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study.
van Seters M; Fons G; van Beurden M
J Reprod Med; 2002 Sep; 47(9):701-5. PubMed ID: 12380448
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
Fox PA; Nathan M; Francis N; Singh N; Weir J; Dixon G; Barton SE; Bower M
AIDS; 2010 Sep; 24(15):2331-5. PubMed ID: 20729710
[TBL] [Abstract][Full Text] [Related]
29. Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.
van Esch EM; van Poelgeest MI; Trimbos JB; Fleuren GJ; Jordanova ES; van der Burg SH
Int J Cancer; 2015 Feb; 136(4):E85-94. PubMed ID: 25220265
[TBL] [Abstract][Full Text] [Related]
30. Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
Orengo I; Rosen T; Guill CK
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S225-8. PubMed ID: 12271283
[TBL] [Abstract][Full Text] [Related]
31. Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.
Trutnovsky G; Reich O; Joura EA; Holter M; Ciresa-König A; Widschwendter A; Schauer C; Bogner G; Jan Z; Boandl A; Kalteis MS; Regauer S; Tamussino K
Lancet; 2022 May; 399(10337):1790-1798. PubMed ID: 35483400
[TBL] [Abstract][Full Text] [Related]
32. Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder.
Nunez-Nateras R; Castle EP; Protheroe CA; Stanton ML; Ocal TI; Ferrigni EN; Ochkur SI; Jacobsen EA; Hou YX; Andrews PE; Colby TV; Lee NA; Lee JJ
Urol Oncol; 2014 Jan; 32(1):45.e23-30. PubMed ID: 24055426
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.
Daayana S; Elkord E; Winters U; Pawlita M; Roden R; Stern PL; Kitchener HC
Br J Cancer; 2010 Mar; 102(7):1129-36. PubMed ID: 20234368
[TBL] [Abstract][Full Text] [Related]
34. Treatment of bowenoid and basaloid vulvar intraepithelial neoplasia 2/3 with imiquimod 5% cream.
Marchitelli C; Secco G; Perrotta M; Lugones L; Pesce R; Testa R
J Reprod Med; 2004 Nov; 49(11):876-82. PubMed ID: 15603097
[TBL] [Abstract][Full Text] [Related]
35. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
[TBL] [Abstract][Full Text] [Related]
36. Effect of immunotherapy on the immune microenvironment in advanced recurrent cervical cancer.
Chen R; Yang W; Li Y; Cheng X; Nie Y; Liu D; Wang H
Int Immunopharmacol; 2022 May; 106():108630. PubMed ID: 35189471
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cutaneous tumors with topical 5% imiquimod cream.
Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C
Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702
[TBL] [Abstract][Full Text] [Related]
38. Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
Tainio K; Jakobsson M; Louvanto K; Kalliala I; Paavonen J; Nieminen P; Riska A
Int J Cancer; 2016 Nov; 139(10):2353-8. PubMed ID: 27428506
[TBL] [Abstract][Full Text] [Related]
39. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Diaz-Arrastia C; Arany I; Robazetti SC; Dinh TV; Gatalica Z; Tyring SK; Hannigan E
Clin Cancer Res; 2001 Oct; 7(10):3031-3. PubMed ID: 11595691
[TBL] [Abstract][Full Text] [Related]
40. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
